Evidence map›Paper›PMID 37917316›Full record

ArticleDrug safety2024

Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.

G Caleb Alexander, Daniel Budnitz, Carmel Hughes, Renke Maas, Alpana Mair, Emily G McDonald, Andreas D Meid, Rupert Payne, Hanna M Seidling, Saad Shakir and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug safety, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

G Caleb AlexanderDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street W6035, Baltimore, MD, 21205, USA. galexan9@jhmi.edu.ORCID http://orcid.org/0000-0002-5622-2986
Daniel BudnitzKenvue, Fort Washington, PA, USA.
Carmel HughesSchool of Pharmacy, Queen's University Belfast, Belfast, UK.
Renke MaasInstitute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Alpana MairEffective Prescribing and Therapeutics, Health and Social Care Directorate, Scottish Government, Edinburgh, UK.
Emily G McDonaldCentre for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, QC, Canada.
Andreas D MeidDepartment of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Rupert PayneExeter Collaboration for Academic Primary Care (APEx), Exeter Medical School, University of Exeter, Exeter, UK.
Hanna M SeidlingDepartment of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Saad ShakirDrug Safety Research Unit, University of Portsmouth, Southampton, UK.
Samy SuissaDepartment of Epidemiology and Biostatistics, and Department of Medicine, McGill University, Montreal, QC, Canada.
Cara TannenbaumFaculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Sebastian SchneeweissBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Tobias DreischulteInstitute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37917316

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.